London, Researchers at Oxford University, working on the Kovid-19 vaccine, said on Friday that they are moving to the next stage of human trials and have begun recruiting more than 10,000 people for it. The first phase of the trial began last month, involving 1,000 healthy adults aged 55 or younger as volunteers. More than 10,200 people, including more than 70 and five to 12-year-old children, will now be included in the study to see the effect of the vaccine on the immune system.
A recent study found that a vaccine called CHADOXVN NCOV-19 showed some promising results in a small group of monkeys. “The COVID-19 vaccine trial team is working hard to assess the impact of the vaccine,” said Sarah Gilbert, a professor of vaccineology at the University’s Jenner Institute.
Also Read: Vaccine did not make that buyer came forward, America signed 300 million vaccine deal
Recently Oxford University had tested in monkeys
Let me tell you that the whole world is battling Corona virus (Kovid-19) at this time. Many treatments and vaccines (vaccines) are being researched at a rapid pace in an attempt to find the epidemic. Researchers from Oxford University, UK are also engaged in this exercise. His Kovid-19 vaccine has been proven to test in six monkeys.
Although the trial has been carried out on a small scale, its effect has been found to be protective. Now this vaccine is being tested on humans. Significantly, more than 100 vaccines are currently underway to fight the corona virus worldwide. According to the study, a single dose of the vaccine can also protect against damage to the lungs and organs that the corona virus can severely affect.
